Logo (Tobramycin 01)
Tobramycin Injection, Solution
Product Images NDC 0409-3578
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Tobramycin (NDC 0409-3578). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Structural Formula Tobramycin Sulfate (Tobramycin 02)
Graphic Reduced Dosage Nomogram (Tobramycin 03)
This text appears to be a chart displaying a reduced dosage nomogram for medication administration. The chart lists creatinine clearance values (in mL/min/1.73 m?) and corresponding percentages of normal, with recommended dosages from Table 3. Additionally, the chart includes serum creatinine values in mg/100 mL. The scales have been adjusted to facilitate dosage calculations.*
Logo (Tobramycin 04)
Label Ndc 0409-3577-01 (Tobramycin 05)
This is a description for a medicine that comes in a multiple-dose 2mlL container, with a National Drug Code (NDC) identification of 0409-3577-11. It is a pediatric prescription with a concentration of 20 mg/2 mL (10 mg/mL) and contains sulfites. It is labeled for LV or IM use, and it must be diluted for IV use. The medicine is distributed by Hospira, Inc. in Lake Forest, IL 60045 USA. The rest of the text is not relevant to the description.*
Principal Display Panel (20 mg/2 mL Vial Tray)
This is a label for a 20 mg/2 mL vial of medication that is intended for intramuscular or intravenous use. Dilution is necessary for intravenous use. The medication has been manufactured by Hospira, Inc, based in the United States and contains sulfites. The label also includes a barcode and product codes, but it is not clear what these codes are for.*
Label Ndc 0409-3578-01 (Tobramycin 07)
This is a medication with the brand name Tobramycinf#s, containing 80mg/2mL of an active ingredient that needs to be diluted for V use. It should be used with caution by individuals with sulfite allergies. The medication is distributed by Hospira, Inc. located in Lake Forest, IL, USA. There are several reference numbers on the packaging, including a National Drug Code (NDC) of 0409-3578-11, and other identifiers like FP0, 7.5 Mil, RL-7492, and HHE-HH#H-AA, which may be used for tracking and inventory purposes. The text also contains a warning and instructions to use the medicine for LV or M use only while also providing a prescription note.*
Principal Display Panel (80 mg/2 mL Vial Tray)
This appears to be a description of a medication in the form of an injection with a NDC (National Drug Code) number of 0409-3578-01. The injection is made in Hungary and distributed by Hospira, Inc. in the USA. The text includes a note that the medication must be diluted for intravenous use and is only available by prescription. There is also mention of a multiple-dose vial. The rest of the text is not legible and appears to be garbled.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
